Vascular Disease, Hypertension, and Prevention tolic function were recorded.All had confirmed normal short axis systolic contractility. Diastolic function was studied by means of tissue doppler. Results: Echocardiographic indices were predictably abnormal, and plasma MMP-9 & TIMP-1 were elevated in HT. Within the hypertensive cohort, LV mass and septal thickness correlated positively with TIMP-1 (Ranked Pearson's correlation r=0.312,p=0.035; r=0.359,p=0.013 respectively). There was a negative correlation between e' and TIMP-1 (r= -0.296,p=0.037). Conclusion: We have defined a novel relationship between elevated TIMP-1, increased LV mass and impaired diastolic relaxation. This suggests a role for this metalloproteinase inhibitor in the patho-physiology of hypertensive heart disease potentially related to diastolic heart failure in HT.
Background: Vascular injury in youth associated to early blood pressure (BP) alterations and other risk factors is not well known. To establish their possible association, pulse wave velocity (PWV), clinical, metabolic and haemodynamic variables were measured in young adults stratified by their blood pressure percentile obtained 13 years earlier. Methods: 385 young subjects (201M) were evaluated at their schools in 1987-88 (12.74±1.65 y). BP was measured 3 times, and the third measure was used for analysis. Body mass index (BMI) was obtained. In 1997 In -2000 , they were examined at the hospital. BP, BMI, waist and hip were obtained and cholesterol (C), tryglicerides, LDL-C, HDL-C, creatinine, plasma glucose and insulin were measured after a 12h fasting. A sample of 60 young adults underwent PWV measurement by Complior method and was stratified according to their former (at school) BP percentile: Group 1 < 50 th percentile (n=25, 11 M) and Group 2 > 95 th percentile (n=35, 19 M). Results: 1) Group 1 had higher age (p<.05) and all comparisons were adjusted for age. 2) Group 2 had higher weight (p<.05), systolic BP (SBP) (p<.03), diastolic BP (DBP) (p<.02), mean BP (MBP) (p<.02), PWV (p<.03), fasting glucose (p<.03) and lower HDL-C (p<.03). 3) PWV correlated positively and significantly with SBP (r=0.333, p<.02), MBP (r=0.303, p<.02) and heart rate (HR) (r=0.284, p<.03) obtained 13 years earlier. 4) PWV showed significant correlations with the following current variables: weight (r=0.403, p<.01), height (r=0.301, p<.02), waist circumference (r=0.347, p<0.01), waist/hip ratio (r=0.328, p=0.01), SBP (r=0.444, p<.01), DBP (r=0.318, p<.02), pulse pressure (PP) (r=0.274, p<.04), MBP (r=0.424, p<.01) and serum creatinin (r=0.400, p<.01). 5) In covariance analysis, when PWV was adjusted for current SBP, DBP, MBP and PP, no significant differences were observed between the groups, although group 2 showed higher means in all comparisons. Conclusion: High BP percentile obtained in adolescence was associated with higher BP and PWV 13 years later. These results suggest that early vascular changes could be identified in young and emphasize that primary prevention must begin early in life. Background: Most epidemiologic studies have focused on the association between the adverse levels of risk variables of metabolic syndrome and the risk of cardiovascular (CV) disease. However, information is lacking on the relation of metabolic syndrome risk variables clustering at favorable levels in childhood and CV disease risk in adulthood.
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Methods:
The study cohort (n=1,474) was examined in childhood (4-17 years) and again in adulthood (18-41 years), with an average follow-up period of 15.8 years in a blackwhite community. The childhood criterion metabolic syndrome variables included the lowest quartiles (specific for age, race, sex and study year) of body mass index, homeostasis model assessment of insulin resistance, systolic blood pressure and total cholesterol/ high-density lipoprotein cholesterol ratio. The measures of CV risk in adulthood included prevalence of metabolic syndrome, parental histories of CV disease, and carotid artery intima-media thickness (IMT) measured in a subsample (n=138).
Results:
In childhood, 9% of the cohort displayed clustering of 3 or 4 criterion risk variables at the bottom quartiles, which was significantly higher than expected by chance alone (P<0.01). These children, compared with those without any risk variables at the bottom quartiles, had a lower prevalence of metabolic syndrome in adulthood (2.3% vs 20.0%, P<0.001). In addition to lower odds for having metabolic syndrome in adulthood (11-fold, P<0.001), they also displayed lower odds for having parental histories of CHD (1.9-fold, P=0.039), hypertension (1.5-fold, P=0.045 ) and type 2 diabetes (1.6-fold, P=0.079). Mean values of carotid IMT in adulthood decreased with an increasing number of risk variables clustering at the bottom quartiles in childhood (P for trend=0.013).
Conclusion:
The constellation of metabolic syndrome variables at low levels in childhood is associated with lower measures of CV risk in adulthood. The beneficial consequence of such a lifetime low-risk profile in youth reinforces the importance of CV disease health promotion and life style modification in early life.
2:15 p.m. low dose ASA alone, the multivariate adjusted significance was 0.01. Conclusion: In a healthy population without known coronary disease, after controlling for major risk factors, the use of ASA and a statin alone remains significantly associated with lower levels of inflammation, and importantly the combination of both a statin and aspirin is a particularly strong independent predictor of lower levels of hs-CRP. These findings suggest that daily statin and aspirin therapy combined may be particularly potent in reducing inflammation in high risk individuals who have not yet had a clinical coronary event.
847-2 Combination Aspirin and Statin Therapy Markedly Reduces C-Reactive Protein Levels in a High-Risk Population Without Coronary Disease
2:30 p.m. Background: Lack of platelet aggregation response to aspirin resistance (AR) has been reported in 5-30% of patients. Using strict criteria for AR, we have shown a three fold increased risk of death, MI and CVA. The underlying mechanisms for the variable effect of aspirin remain unclear and are likely multi-factorial. Polymorphisms in platelet surface receptors may alter the response of platelets to pharmacologic agents and play a role in aspirin sensitivity. Methods: We examined 7 candidate single nucleotide polymorphisms in the COX-1, COX-2, GPIIIa, and P 2 Y 1 (P2RY1) genes in 332 patients on aspirin with a history of MI from the Gene Quest 2 database. Aspirin resistance was assessed using optical aggregation in response to arachidonic acid and ADP. Aspirin sensitive (aggregation <20%) and resistant (>20%) subjects were compared using multiple logistic regression. DNA was genotyped using standard PCR techniques. Results: In the study population, 235(71%) were classified as aspirin sensitive and 95(29%) were classified as aspirin resistant. Clinical comparisons between aspirin sensitive and aspirin resistant patients revealed a significant difference between the groups in age (63.3 y/68.4 y), HDL cholesterol (39 mg/dl/35.6 mg/dl), and incidence of diabetes (22%/37%). Using logistic regression analysis, patients with the P2RY1 C/T893 genotype displayed a statistically significant 3-fold higher risk of aspirin resistance over those with the P2RY1 C/C893 genotype. The risk of aspirin resistance remained even after adjusting for the above confounding variables: Adjusted OR 2.72 (95% C.I. 1.12, 6.57). Single nucleotide polymorphisms in other candidate genes were not associated with aspirin resistance.
847-3 Aspirin Resistance Is Associated With a Single
Conclusions: There are demographic differences between aspirin sensitive and aspirin resistant patients which are in agreement with previous reports. After controlling for these variables, the P2RY1 C/T893 polymorphism is associated with decreased platelet responsiveness to aspirin. Polymorphisms in the P 2 Y 1 receptor gene may provide a genetic link in the variable clinical responsiveness of patients to aspirin and requires confirmation and elucidation of the mechanism.
2:45 p.m. Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthase. In human subjects, its levels are related to endothelial dysfunction and the progression of carotid atherosclerosis. In patients with end-stage renal disease, ADMA is prospectively associated with the risk of major cardiovascular events and death. It was the aim of the CARDIAC study (Coronary Artery Risk Determination investigating the Influence of ADMA Concentration) to assess the relationship between ADMA concentration and the risk for coronary heart disease (CHD) in a large population including subjects with a broad range of established coronary risk factors of both sexes and with normal renal function. We also studied the relationship between ADMA and traditional risk factors in risk determination. Methods. 408 patients with established CHD and 408 controls matched for age and sex were enrolled. Besides traditional risk factors, plasma levels of ADMA and its biologically inactive regioisomer, symmetric dimethylarginine (SDMA), and L-arginine were determined.
847-4 Asymmetric Dimethylarginine and the Risk of Coronary
Results. CHD patients had significantly higher ADMA plasma concentration than controls (median, 0.91 vs. 0.70 µmol/L; p<0.0001). ADMA was an independent predictive factor for the risk of CHD, whereas SDMA was not associated with CHD. ADMA levels significantly increased with increasing number of established cardiovascular risk factors present (p<0.01). The presence of hypertension was associated with significantly higher ADMA levels (median, 0.95 vs. 0.87 µmol/l; p<0.05), whereas hypercholesterolemia was associated with lower ADMA (0.85 vs. 1.03 µmol/l; p<0.05; probably due to the high rate of treated hypercholesterolemia), and diabetes mellitus had no significant effect on ADMA. Former smokers had higher ADMA than current smokers or non-smokers (1.16 vs. 0.70 and 0.88 µmol/l, respectively; p<0.01).
Conclusions. The present data show for a large group of subjects of both sexes and with a broad range of established coronary risk factors that ADMA is an independent marker of CHD. Thus, determination of ADMA may help to identify patients at risk for coronary events beyond currently established risk factors.
3:00 p.m.
847-5 Systolic Blood Pressure Measured Serially From Childhood to Adulthood Predicts Arterial Stiffness in Young Adults: The Bogalusa Heart Study
Shengxu Li, Wei Chen, Sathanur R. Srinivasan, Gerald S. Berenson, Tulane University, New Orleans, LA Backgroud: Arterial stiffness is associated with cardiovascular risk factors and is an independent predictor of cardiovascular disease and events even after adjusting for other traditional risk factors. However, no data are available regarding the relationship of arterial stiffness in young adults to different risk factors measured in childhood, adulthood, or as a cumulative burden from childhood to adulthood.
Methods:
The study sample included 839 young adults (72% whites, 44% males) aged 24 to 44 years who had at least four measurements of traditional risk factors including body mass index (BMI), systolic blood pressure, low-and high-density lipoprotein (LDL and HDL) cholesterols, and triglycerides since childhood. The average follow-up period was 26.5 years. Brachial to ankle pulse wave velocity (baPWV) by oscillometric method was used as a measure of arterial stiffness. Cumulative burden of risk factors since childhood was measured as area under the curve divided by follow-up years. Results: Males vs females and black vs whites had higher levels of baPWV (P<0.001). Systolic blood pressure, BMI, and HDL cholesterol measured in childhood, all the risk factors measured in adulthood, and cumulative burdens of systolic blood pressure, triglycerides, BMI, and HDL cholesterol were significant risk factors for baPWV in young adults in univariate analyses. In multiple regression analyses, childhood systolic blood pressure, adulthood systolic blood pressure and triglycerides, and cumulative burdens of systolic blood pressure and triglycerides since childhood were significant and independent risk factors for baPWV in young adults.
Conclusion:
These results indicate that among the traditional cardiovascular risk factors, systolic blood pressure measured either in childhood, adulthood, or as a cumulative burden since childhood is a consistent predictor of arterial stiffness in young adults, and underscores its importance in the process of arterial stiffening.
